Seasonal Affective Disorder Therapeutics Market: "Bright Light Therapy" Remains First Line of Intervention
Search jobs Seasonal Affective Disorder Therapeutics Market: “Bright Light Therapy” Remains First Line of Intervention The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter...
Koninklijke Philips Teva Pharmaceuticals Inc Route Of Administration Oral Janssen Pharmaceuticals Inc Cancer Research Centers Eli Lily Company
Source: pharmiweb.com